Impact BioMedical Inc. (IBO)

Impact BioMedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	2	0	0	0.05
Cash & Short-Term Investments	0	2	0	0	0.05
Cash Growth	-99.85%	199800.00%	-50.00%	-95.65%	-
Accounts Receivable	0.01	-	-	-	-
Other Receivables	-	-	0.13	-	-
Total Trade Receivables	0.01	-	0.13	-	-
Inventory	0.06	-	-	-	-
Other Current Assets	0.34	0.45	0.2	0.12	0.24
Total Current Assets	0.41	2.45	0.33	0.12	0.29
Net Property, Plant & Equipment	-	0.02	0.29	0.28	0.78
Other Intangible Assets	16.99	17.81	18.92	20.03	21.15
Goodwill	-	-	25.09	25.09	25.09
Long-Term Investments	-	-	-	0.78	5.08
Other Long-Term Assets	-	0.02	-	0.19	2.68
Total Assets	17.41	20.29	44.63	46.5	56.43
Accounts Payable	0.97	0.71	0.83	0.54	0.12
Accrued Expenses	0.19	0.19	0.23	0.06	0.01
Short-Term Debt	-	8.88	12.07	9.99	12.52
Total Current Liabilities	1.16	9.79	13.14	10.59	12.65
Other Long-Term Liabilities	0.69	3.27	3.24	3.24	3.86
Total Long-Term Liabilities	0.69	3.27	3.24	3.24	3.86
Total Liabilities	1.85	13.05	16.37	13.83	16.5
Preferred Stock	-	0.06	0.06	-	-
Common Stock	0.11	0.01	0.01	0.07	0.07
Additional Paid-in Capital	62.01	41.86	38.11	38.11	38.11
Retained Earnings	-49.51	-37.67	-12.96	-8.63	-1.57
Total Common Shareholders' Equity	12.61	4.26	25.22	29.56	36.61
Minority Interest	2.95	2.98	3.04	3.11	3.32
Shareholders' Equity	15.56	7.24	28.26	32.67	39.92
Total Liabilities & Equity	17.41	20.29	44.63	46.5	56.43
Total Debt	0	8.88	12.07	9.99	12.52
Net Cash (Debt)	0	-6.88	-12.07	-9.99	-12.48
Net Cash Per Share	-	-0.64	-0.20	-0.14	-0.18
Book Value	12.61	4.26	25.22	29.56	36.61
Book Value Per Share	0.40	0.40	0.42	0.42	0.52
Tangible Book Value	-4.39	-13.55	-18.79	-15.57	-9.63
Tangible Book Value Per Share	-0.14	-1.26	-0.31	-0.22	-0.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q